Cargando…
(123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation
PURPOSE: Heart failure (HF) is a primary cause of morbidity and mortality worldwide, with significant impact on life quality and extensive healthcare costs. Assessment of myocardial sympathetic innervation function plays a central role in prognosis assessment in HF patients. The aim of this review i...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852124/ https://www.ncbi.nlm.nih.gov/pubmed/36071220 http://dx.doi.org/10.1007/s00259-022-05941-3 |
_version_ | 1784872542271438848 |
---|---|
author | Gargiulo, Paola Acampa, Wanda Asile, Gaetano Abbate, Vincenza Nardi, Ermanno Marzano, Federica Assante, Roberta Nappi, Carmela Parlati, Antonio Luca Maria Basile, Christian Dellegrottaglie, Santo Paolillo, Stefania Cuocolo, Alberto Perrone-Filardi, Pasquale |
author_facet | Gargiulo, Paola Acampa, Wanda Asile, Gaetano Abbate, Vincenza Nardi, Ermanno Marzano, Federica Assante, Roberta Nappi, Carmela Parlati, Antonio Luca Maria Basile, Christian Dellegrottaglie, Santo Paolillo, Stefania Cuocolo, Alberto Perrone-Filardi, Pasquale |
author_sort | Gargiulo, Paola |
collection | PubMed |
description | PURPOSE: Heart failure (HF) is a primary cause of morbidity and mortality worldwide, with significant impact on life quality and extensive healthcare costs. Assessment of myocardial sympathetic innervation function plays a central role in prognosis assessment in HF patients. The aim of this review is to summarize the most recent evidence regarding the clinical applications of iodine-123 metaiodobenzylguanidine ((123)I-MIBG) imaging in patients with HF and related comorbidities. METHODS: A comprehensive literature search was conducted on PubMed and Web of Science databases. Articles describing the impact of (123)I-MIBG imaging on HF and related comorbidities were considered eligible for the review. RESULTS: We collected several data reporting that (123)I-MIBG imaging is a safe and non-invasive tool to evaluate dysfunction of cardiac sympathetic neuronal function and to assess risk stratification in HF patients. HF is frequently associated with comorbidities that may affect cardiac adrenergic innervation. Furthermore, HF is frequently associated with comorbidities and chronic conditions, such as diabetes, obesity, kidney disease and others, that may affect cardiac adrenergic innervation. CONCLUSION: Comorbidities and chronic conditions lead to more severe impairment of sympathetic nervous system in patients with HF, with a negative impact on disease progression and outcome. Cardiac imaging with (123)I-MIBG can be a useful tool to reduce morbidity and prevent adverse events in HF patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-022-05941-3. |
format | Online Article Text |
id | pubmed-9852124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98521242023-01-21 (123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation Gargiulo, Paola Acampa, Wanda Asile, Gaetano Abbate, Vincenza Nardi, Ermanno Marzano, Federica Assante, Roberta Nappi, Carmela Parlati, Antonio Luca Maria Basile, Christian Dellegrottaglie, Santo Paolillo, Stefania Cuocolo, Alberto Perrone-Filardi, Pasquale Eur J Nucl Med Mol Imaging Review Article PURPOSE: Heart failure (HF) is a primary cause of morbidity and mortality worldwide, with significant impact on life quality and extensive healthcare costs. Assessment of myocardial sympathetic innervation function plays a central role in prognosis assessment in HF patients. The aim of this review is to summarize the most recent evidence regarding the clinical applications of iodine-123 metaiodobenzylguanidine ((123)I-MIBG) imaging in patients with HF and related comorbidities. METHODS: A comprehensive literature search was conducted on PubMed and Web of Science databases. Articles describing the impact of (123)I-MIBG imaging on HF and related comorbidities were considered eligible for the review. RESULTS: We collected several data reporting that (123)I-MIBG imaging is a safe and non-invasive tool to evaluate dysfunction of cardiac sympathetic neuronal function and to assess risk stratification in HF patients. HF is frequently associated with comorbidities that may affect cardiac adrenergic innervation. Furthermore, HF is frequently associated with comorbidities and chronic conditions, such as diabetes, obesity, kidney disease and others, that may affect cardiac adrenergic innervation. CONCLUSION: Comorbidities and chronic conditions lead to more severe impairment of sympathetic nervous system in patients with HF, with a negative impact on disease progression and outcome. Cardiac imaging with (123)I-MIBG can be a useful tool to reduce morbidity and prevent adverse events in HF patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-022-05941-3. Springer Berlin Heidelberg 2022-09-08 2023 /pmc/articles/PMC9852124/ /pubmed/36071220 http://dx.doi.org/10.1007/s00259-022-05941-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Gargiulo, Paola Acampa, Wanda Asile, Gaetano Abbate, Vincenza Nardi, Ermanno Marzano, Federica Assante, Roberta Nappi, Carmela Parlati, Antonio Luca Maria Basile, Christian Dellegrottaglie, Santo Paolillo, Stefania Cuocolo, Alberto Perrone-Filardi, Pasquale (123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation |
title | (123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation |
title_full | (123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation |
title_fullStr | (123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation |
title_full_unstemmed | (123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation |
title_short | (123)I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation |
title_sort | (123)i-mibg imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852124/ https://www.ncbi.nlm.nih.gov/pubmed/36071220 http://dx.doi.org/10.1007/s00259-022-05941-3 |
work_keys_str_mv | AT gargiulopaola 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT acampawanda 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT asilegaetano 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT abbatevincenza 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT nardiermanno 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT marzanofederica 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT assanteroberta 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT nappicarmela 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT parlatiantoniolucamaria 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT basilechristian 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT dellegrottagliesanto 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT paolillostefania 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT cuocoloalberto 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation AT perronefilardipasquale 123imibgimaginginheartfailureimpactofcomorbiditiesoncardiacsympatheticinnervation |